Soleus Capital Management, L.P. Pulmonx Corp Transaction History

Soleus Capital Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$10.78 - $13.65 $323,400 - $409,500	-30,000 Reduced 42.25%	41,000 $537,000
Q4 2022 Feb 14, 2023	BUY	$4.92 - $17.35 $349,320 - $1.23 Million	71,000 New	71,000 $598,000
Q4 2021 Feb 14, 2022	SELL	$29.72 - $45.1 $2.6 Million - $3.95 Million	-87,612 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$35.98 - $44.48 $84,984 - $105,061	2,362 Added 2.77%	87,612 $3.15 Million
Q2 2021 Aug 16, 2021	BUY	$37.61 - $48.0 $3.21 Million - $4.09 Million	85,250 New	85,250 $3.76 Million

116

30.6M

400

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $309M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.